Simonaro, Calogera M

Joint and bone disease in mucopolysaccharidoses VI and VII: identification of new therapeutic targets and biomarkers using animal models. [electronic resource] - Pediatric research May 2005 - 701-7 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

0031-3998

10.1203/01.PDR.0000156510.96253.5A doi


Animals
Antimetabolites--pharmacology
Apoptosis
Biomarkers--metabolism
Bone Diseases--complications
Bromodeoxyuridine--pharmacology
Cats
Cell Proliferation
Cells, Cultured
Chondrocytes--cytology
Cytokines--metabolism
Disease Models, Animal
Dogs
Immunoassay
Immunohistochemistry
Inflammation
Joint Diseases--complications
Matrix Metalloproteinase 2--biosynthesis
Matrix Metalloproteinase 9--biosynthesis
Mucopolysaccharidosis VI--complications
Mucopolysaccharidosis VII--complications
Nitric Oxide--metabolism
Osteonectin--metabolism
Rats
Reverse Transcriptase Polymerase Chain Reaction
Tibia--metabolism
Time Factors
Tissue Inhibitor of Metalloproteinase-1--biosynthesis
Transforming Growth Factor beta--biosynthesis